Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL ...
TScan
TScan Therapeutics (TCRX) Earnings Date and Reports 2026
TCR-T Cancer Therapies | TScan Therapeutics
Longwood Fund - TScan Therapeutics
TScan Therapeutics Formed to Overcome Challenges of Current ...
TScan Therapeutics May 2025 slides: advancing TCR-T therapies with ...
TScan Therapeutics, Inc. - UNITED STATES SECURITIES AND EXCHANGE ...
TScan Therapeutics Announces Upcoming Presentation at the American ...
TScan Therapeutics Profile
TScan Therapeutics简介-TScan Therapeutics成立时间|总部|股票代码-排行榜123网
TScan Therapeutics shares soar on news of Amgen deal - Boston Business ...
TScan Therapeutics (TCRX) Earnings Date and Reports 2025
TScan Therapeutics on LinkedIn: #celltherapy #tcells
#asgct #tscan #celltherapy | TScan Therapeutics
TScan Therapeutics | LinkedIn
TScan Therapeutics IPO Presentation Deck | Slidebook.io
Home – TScan Therapeutics
Clinical-Stage Biotech Company | About TScan Therapeutics
Who is TScan Therapeutics? - A Cure In Sight™ - Ocular Melanoma
TScan Therapeutics receives FDA clearance for IND applications
TScan Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
TScan Reaches FDA Agreement on TSC-101 Pivotal Trial | TCRX Stock News
TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands ...
TScan Therapeutics logo in transparent PNG and vectorized SVG formats
TScan Therapeutics posts $129.8M 2025 loss, cash to 2H 2027 | TCRX ...
TScan Completes Trial Enrollment, FDA Clears New Heme Drugs
TScan Therapeutics – Environments at Work
#workboston #celltherapy | TScan Therapeutics | 10 comments
TScan Therapeutics Secures Funding Surge with Warrant Sale - Investors ...
TScan Therapeutics cuts 75% of workforce, pauses Phase 3 ALLOHA-2 trial ...
TScan Therapeutics Releases Q2 2026 Financial Results - Alphastreet
H.C. Wainwright downgrades Tscan stock rating on restructuring By ...
TScan Therapeutics, Inc. (TCRX): Neutral Rating Issued Amid Market ...
TScan Therapeutics Announces Closing of Public Offering
H.C. Wainwright reiterates Tscan Therapeutics stock rating at buy By ...
TSCAN THERAPEUTICS Aktienkurs | Aktien A3CPAN | US89854M1018 Börsenkurs
Tscan Layoffs: 96 Jobs in MA - Sep 2026 | Layoff IQ
TScan Therapeutics Inc. Company & People | TCRX | Barron's
TScan Therapeutics (TCRX) - Market Cap Trend (2021-2026)
Why is TScan Therapeutics stock collapsing today? By Investing.com
TScan Therapeutics layoffs: Waltham biotech cuts 96 jobs after funding ...
TScan Therapeutics Announces Strategic Reorganization to Focus on in ...
ArsenalBio and TScan cut jobs to focus on in vivo - EMJ GOLD
Tscan Therapeutics (TCRX) Insider Trades - Executive Stock
صندوق فروشگاهی Dell3030i54+فیش پرینتر TSCAN در زاهدان
TScan Appoints Jason Amello As CFO
TScan posts Q1 2026 results and pipeline update | TCRX 8-K Filing
TScan Therapeutics (TCRX) — Markets
TScan Therapeutics, Inc. (TCRX) latest stock news and headlines – Yahoo ...
TCRX Investor Relations - TScan Therapeutics Inc - Alpha Spread
TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering ...
خرید و قیمت بارکدخوان تی اسکن TS20 دوبعدی باسیم Tscan TS-20 | ترب
TCRX News Today | Why did TScan Therapeutics stock drop today?
TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2 ...
TScan Therapeutics Announces Launch of Proposed Public Offering
TScan Therapeutics, Inc. (TCRX) Interactive Stock Chart - Yahoo Finance
TScan Therapeutics, Inc. (TCRX) Stock Price, Quote, News & Analysis ...
TScan Therapeutics Announces Two-Year Relapse Data for TSC-101 Cell ...
TScan Therapeutics - TCRX - Stock Price Today - Zacks
TScan Therapeutics Inc. (TCRX) Stock Price Today - The Wall Street Journal
TScan Therapeutics (TCRX) Earnings Report: Key Numbers & Transcript Summary
TCRX Stock Price | TScan Therapeutics Inc. Stock Quote (U.S.: Nasdaq ...
TScan-II: A genome-scale platform for the de novo identification of CD4 ...
Brian Silver Net Worth, Biography, and Insider Trading
T細胞療法新創TScan C輪募資1億美元 推動2個血液腫瘤療法進臨床-環球生技月刊
TScan:一种全基因组、高通量的T细胞受体筛选技术 - 知乎
HC Wainwright Issues Optimistic Estimate for TCRX Earnings - American ...
TScan's strategy unaffected by Amgen scrapping $500M+ collab
白帽子的新战友:一个会自己找漏洞的 AI 智能体 | CN-SEC 中文网
Is Medicus Pharma a Good Stock to Buy Now? MDCX AI Buy/Sell Signals ...
Massachusetts Layoffs 2026 — WARN Act Notices
Trailer association will engage govt to end quackery in industry ...
Jeecg漏洞总结及tscan poc分享 - 今日头条
Is Natera a Good Stock to Buy Now? NTRA AI Buy/Sell Signals | Danelfin
Is Sana Biotechnology a Good Stock to Buy Now? SANA AI Buy/Sell Signals ...
Is MoonLake a Good Stock to Buy Now? MLTX AI Buy/Sell Signals | Danelfin
flatexDEGIRO: Aufsichtsratschef Lotter tritt zurück – Müller übernimmt ...
9月初多家跨国药企、Biotech 裁员,同步终止管线_药企,裁员-制药网
Fräulein Nass on X: "Ich blinke auch nicht. Das macht mich nur müde" / X
Is Moderna a Good Stock to Buy Now? MRNA AI Buy/Sell Signals | Danelfin